TCAF2与免疫微环境相关,促进病变发生,并损害质瘤的预后
Yongshuai Li1, Jiaqiong Li1, Huaqing Chen2
1Department of Critical Care Medicine, Xuzhou Central Hospital, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu 221009, China.
Gene
|July 28, 2023
概括
在质瘤中,TRPM8通道相关因子2 (TCAF2) 被上调,促进瘤生长和攻击性. 这项研究揭示了TCAF2作为潜在的治疗标和质瘤患者的预后标记.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 质瘤是一种常见且具有攻击性的初级内瘤.
- 与TRPM8通道相关的2因子 (TCAF2) 与各种人类癌症有关.
- TCAF2在质瘤病变发生中的特定作用仍然在很大程度上是未知的.
研究的目的:
- 为了研究TCAF2在质瘤中的表达和功能.
- 确定TCAF2表达与质瘤恶性病变,预后和瘤免疫微观环境之间的相关性.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库进行生物信息分析.
- 进行了体外测试 (EdU,transwell) 和体内异种移植模型.
- 进行免疫组织化学测试以评估TCAF2表达水平.
主要成果:
- 在质瘤组织中,TCAF2的表达显著上调.
- 升高的TCAF2水平与较高的瘤等级和较差的临床结果相关.
- 通过调节新陈代谢途径和免疫微环境,TCAF2促进质瘤恶性瘤.
结论:
- 在质瘤的发展和进展中,TCAF2作为瘤基因起作用.
- 在质瘤治疗中,TCAF2是一个有前途的治疗点.
- 对于质瘤患者来说,TCAF2可以作为一个有价值的预后生物标志物.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558